We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Kneat.com Inc (KSI) NPV

Sell:3.65 CAD Buy:3.78 CAD Change: No change
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:3.65 CAD
Buy:3.78 CAD
Change: No change
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:3.65 CAD
Buy:3.78 CAD
Change: No change
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.

Contact details

Unit 7,Castletroy Park Business Centre,
V94 5F68
+353 (61) 203826

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
315.62 million CAD
Shares in issue:
84.52 million
Health Care Technology
Toronto Stock Exchange
Canadian dollars

Key personnel

  • Edmund Ryan
    Chief Executive Officer, Director
  • Brian Ahearne
    Co-Founder, Chief Information Officer
  • Hugh Kavanagh
    Chief Financial Officer
  • Fiona Mccarthy
    Chief People and Culture Officer
  • Jacob Michelsen
    Senior Vice President - Global Sales & Marketing
  • Keith Holmes
    Chief Technical Officer
  • Kevin Fitzgerald
    Chief Product Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.